Validating the prognostic value of muscle changes in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt  

作　　者：Zhang Wen Shuyue Tuo Ying Liu Jia Yuan Yong Li Lu Li Shejiao Dai Xinxing Tantai 

机构地区：[1]Department of Gastroenterology,The Second Affiliated Hospital of Xi’an Jiaotong University,Xi’an,China [2]Clinical Research Center for Gastrointestinal Diseases of Shaanxi Province,The Second Affiliated Hospital of Xi’an Jiaotong University,Xi’an,China

出　　处：《Hepatobiliary Surgery and Nutrition》2024年第6期1010-1014,I0008,共6页肝胆外科与营养(英文)

基　　金：supported by grants from Xi’an Science and Technology Plan Project(No.22YXYJ0122);IIT Clinical Research Fund of The Second Affiliated Hospital of Xi’an Jiaotong University(M074).

摘　　要：A multicenter prospective observational study by Di Cola et al.(1)examined the significant impact of individual muscle changes and their combinations on the prognosis of cirrhosis.In their study(1),the 1-year cumulative incidence of death in patients with either sarcopenia and myosteatosis(13.8%)or isolated myosteatosis(13.4%)was more than twice that in patients without muscle changes(5.2%)or with isolated sarcopenia(5.6%).

关 键 词：CIRRHOSIS SARCOPENIA myosteatosis transjugular intrahepatic portosystemic shunt(TIPS) SURVIVAL 

分 类 号：R73[医药卫生—肿瘤]